Nikolaos Stergiopulos

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485.

Mallinckrodt Brand Pharmaceuticals, Inc. engages in the manufacture of pharmaceutical and health products. The company was founded on September 23, 2015 and is headquartered in Hazelwood, MO.

Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA.

Renaissance Management SA (Renaissance) is an independent venture capital firm headquartered in Lausanne, Switzerland. The firm was founded in 1997.

BlueOcean Ventures SA (BlueOcean Ventures) is a venture capital firm founded in 2007 by Maurice Olivier, Faris Sabeti and Emmanuel de Watteville. The firm is headquartered in Geneva, Switzerland.

Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC.

OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA.

Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.

Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland.

Cerchia AG is a company based in Zug, CH that was founded in 2020 by Michaël Rey, Thomas Zehnder, and Fabian Bachmann. Cerchia is located in the heart of the Crypto Valley. The Swiss company specializes in connecting real world asset (RWA) thought leaders with institutional investors. The company's services include animation of natural disasters from 1990-2021, such as storms, floods, hail, earthquakes, cold and frost, visualized by James Eagle. Michaël Rey has been the CEO since 2020.